MiNK Therapeutics, Inc. (NASDAQ:INKT) Sees Large Decline in Short Interest
MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totalling 117,600 shares, a decline of 31.3% from the May 31st total of 171,300 shares. Currently, 2.2% of the shares of the stock are short sold. Based […]
More Stories
Watsco Inc (WSO.B) To Go Ex-Dividend on July 16th
Watsco Inc (NYSE:WSO.B – Get Free Report) declared a quarterly dividend on Monday, July 1st, Zacks reports. Shareholders of record...
Collins Foods Limited (CKF) to Issue Final Dividend of $0.16 on August 5th
Collins Foods Limited (ASX:CKF – Get Free Report) declared a final dividend on Monday, July 1st, MarketIndexAU reports. Investors of...
Repligen Co. (NASDAQ:RGEN) Receives $197.75 Average PT from Analysts
Repligen Co. (NASDAQ:RGEN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eleven ratings...
Brokerages Set HEICO Co. (NYSE:HEI) Target Price at $236.00
Shares of HEICO Co. (NYSE:HEI – Get Free Report) have received an average rating of “Moderate Buy” from the nine...
Newmont Co. (NYSE:NEM) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Newmont Co. (NYSE:NEM – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen...
STMicroelectronics (NYSE:STM) Given Average Rating of “Moderate Buy” by Analysts
Shares of STMicroelectronics (NYSE:STM – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven...